LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
LLY
974.96
-1.19%↓
JNJ
222.47
-0.89%↓
ABBV
202.58
-1.21%↓
UNH
369.71
+0.7%↑
AZN
182.23
-1.36%↓
Overview
Share price change
24h
Current
Min
13.94
Max
16.26
Income | -2.2M -6.9M |
|---|---|
Sales | -999K 2.1M |
EPS | -2.04 |
Profit margin | -321.579 |
Employees | 50 |
EBITDA | -2.5M -6.3M |
Market Cap | 1.5M 42M |
|---|---|
Previous open | 0.89 |
Previous close | 16.04 |
Technical Score
By Trading Central
Confidence
Bearish Evidence
0.4084 / 0.4998 Support & Resistance
Ekso Bionics Holdings Chart
Past performance is not a reliable indicator of future results.
Related News
7 May 2026, 23:58 UTC
OCBC's First-Quarter Net Profit Rose on Record Noninterest Income
DJ
Read
7 May 2026, 22:57 UTC
Australia's Macquarie Beats Consensus With 30% Fiscal Year Profit Jump
DJ
Read
7 May 2026, 23:52 UTC
CoreWeave Stock Dives on Weak Outlook -- Barrons.com
DJ
Read
7 May 2026, 23:45 UTC
Nikkei May Decline Amid Middle East Uncertainty -- Market Talk
DJ
Read
7 May 2026, 23:39 UTC
Gold Rises on Signs of Ongoing U.S.-Iran Tensions -- Market Talk
DJ
Read
7 May 2026, 23:28 UTC
Australian Budget Set to Contain A$64B in Spending Cuts-- Market Talk
DJ
Read
7 May 2026, 23:11 UTC
OCBC Group CEO: Well-Positioned to Navigate Uncertainties, Deliver Sustainable Long-Term Value >O39.SG
DJ
Read
7 May 2026, 23:06 UTC
Oversea-Chinese Banking Corp. 1Q Net Interest Margin 1.76%, Down 28 Bps on Year >O39.SG
DJ
Read
7 May 2026, 23:05 UTC
Oversea-Chinese Banking Corp.: Solid 1Q Performance Underpinned by Record Non-Interest Income >O39.SG
DJ
Read
7 May 2026, 23:04 UTC
Oversea-Chinese Banking Corp. 1Q Non-Interest Income S$1.61B Vs. S$1.31B >O39.SG
DJ
Read
7 May 2026, 23:03 UTC
Oversea-Chinese Banking Corp. 1Q Net Interest Income S$2.22B Vs. S$2.35B >O39.SG
DJ
Read
7 May 2026, 23:03 UTC
Oversea-Chinese Banking Corp. 1Q Net S$1.97B Vs. Net S$1.88B >O39.SG
DJ
Read
7 May 2026, 23:02 UTC
Oversea-Chinese Banking Corp. 1Q Total Income S$3.83B Vs. S$3.66B >O39.SG
DJ
Read
7 May 2026, 23:00 UTC
Australia's Federal Budget Likely to Contain Significant Reforms -- Market Talk
DJ
Read
7 May 2026, 22:45 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Read
7 May 2026, 22:45 UTC
Lyft Says Efforts to Service Waymo's AVs Are Underway -- Market Talk
DJ
Read
7 May 2026, 22:42 UTC
Australia's Macquarie Beats Consensus With 30% FY Profit Jump
DJ
Read
7 May 2026, 22:33 UTC
Gilead Stock Falls. A Massive Acquisition Spree Is Coming at a Cost. -- Barrons.com
DJ
Read
7 May 2026, 22:32 UTC
Macquarie FY Total Customer Deposits A$221.5B Vs. A$177.7B>MQG.AU
DJ
Read
7 May 2026, 22:31 UTC
Macquarie FY Return on Equity 14.0% Vs. 11.2%>MQG.AU
DJ
Read
7 May 2026, 22:31 UTC
Macquarie: 68% of FY Income From International >MQG.AU
DJ
Read
7 May 2026, 22:30 UTC
Macquarie Bank Year-End CET1 Level 2 Ratio 12.8%>MQG.AU
DJ
Read
7 May 2026, 22:30 UTC
Macquarie Capital Surplus A$9.3B at March 31 Vs. A$9.5B a Year Earlier>MQG.AU
DJ
Read
7 May 2026, 22:29 UTC
Macquarie CEO: Well-Positioned for Superior Medium-Term Performance>MQG.AU
DJ
Read
7 May 2026, 22:28 UTC
Macquarie: Continues a Conservative Approach to Capital, Funding, Liquidity>MQG.AU
DJ
Read
7 May 2026, 22:28 UTC
Macquarie: Continues to Maintain a Cautious Stance>MQG.AU
DJ
Read
7 May 2026, 22:27 UTC
Macquarie: Decision Recognizes Prevailing Market Conditions>MQG.AU
DJ
Read
7 May 2026, 22:27 UTC
Macquarie Has Not Purchased Shares Since Extending the Buyback>MQG.AU
DJ
Read
7 May 2026, 22:26 UTC
Macquarie to End Share Buyback Extended in November>MQG.AU
DJ
Read
7 May 2026, 22:25 UTC
Macquarie Commodities and Global Markets FY Net Profit Contribution A$4.2B, Up 49% on Year>MQG.AU
DJ
Read
Peer Comparison
Price change
Ekso Bionics Holdings Forecast
Rating Consensus
By TipRanks
0 ratings
0
Buy
0
Hold
0
Sell
Based on 0 analysts giving stock ratings to Ekso Bionics Holdings - Dist in the past 3 months.
Technical Score
By Trading Central
Short Term
Bearish Evidence
Recent bearish events outweigh bullish events.
Intermediate Term
Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Long Term
No Evidence
There are no events.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$